-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 27, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on June 27, 2019, Euticals Inc., 2460 W Bennett Street, Springfield, Missouri 65807-1229 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance Drug code Schedule Gamma Hydroxybutyric Acid 2010 I Amphetamine 1100 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Phenylacetone 8501 II Methadone 9250 II Methadone intermediate 9254 II Oripavine 9330 II Tapentadol 9780 II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.
Start SignatureEnd Signature End Supplemental InformationDated: October 18, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-23499 Filed 10-25-19; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 10/28/2019
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2019-23499
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 27, 2019.
- Pages:
- 57748-57748 (1 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2019-23499.pdf